Feb
07
In 2017, the American Cancer Society awarded $112 million for cancer research.[1] The National Institute of Health FY17 budget for cancer research was nearly $6 billion.[2]
Pharma companies are pouring billions of R&D dollars into developing new treatments for cancer and are looking for the best ways to maximize those investments. One of the, most effective research tools available and one increasingly leveraged by biopharma is artificial intelligence (AI), used to help unlock the complex mechanisms of cancer.
Oncology is an enormously complicated field, so it’s no surprise that...
